Phase I/II study on stereotactic hypofractionated onceweekly radiation therapy (SHORT) for localized prostate cancer.

被引：0
|
作者：
Mallick, Indranil
Arunsingh, Moses
Prasath, Sriram
Arun, B.
Roy, Paromita
Dabkara, Deepak
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 06期
关键词：
D O I：
10.1200/JCO.2017.35.6_suppl.130
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
130
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A Phase I/II Study of Stereotactic Hypofractionated Once-weekly Radiation Therapy (SHORT) for Prostate Cancer
    Mallick, I
    Arunsingh, M.
    Chakraborty, S.
    Arun, B.
    Prasath, S.
    Roy, P.
    Dabkara, D.
    Achari, R.
    Chatterjee, S.
    Gupta, S.
    CLINICAL ONCOLOGY, 2020, 32 (02) : E39 - E45
  • [2] Health-related quality of life outcomes in a phase I/II study of stereotactic hypofractionated once-weekly radiation therapy (SHORT) for nonmetastatic prostate cancer.
    Mallick, Indranil
    Arunsingh, Moses
    Gupta, Sujoy
    Mukherjee, Satyadip
    Chatterjee, Sanjoy
    Shrimali, Raj K.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [3] Hypofractionated stereotactic body radiotherapy for localized prostate cancer.
    Ali, M.
    Collett, B.
    Stacy, D.
    Hill, K.
    Howard, L.
    Turner, C.
    Chalian, V.
    Grampsas, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] A Phase I/II Trial of Increasingly Hypofractionated Radiation Therapy for Prostate Cancer
    Ritter, M. A.
    Forman, J. D.
    Kupelian, P. A.
    Petereit, D. G.
    Lawton, C. A.
    Chappell, R. J.
    Tome, W. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S80 - S81
  • [5] Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer
    Lara, Pedro C.
    Rodriguez-Melcon, Juan I.
    Palacios-Eito, Amalia
    Lozano, Antonio
    Hervas-Moron, Asuncion
    Villafranca, Elena
    Gomez-Iturriaga, Alfonso
    Sancho, Gemma
    Maldonado, Xavier
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Phase I/II study of ultra hypofractionated radiation for prostate cancer (SHORT): Long-term outcomes
    Arunsingh, Moses
    Mallick, Indranil
    Balakrishnan, Arun
    Prasath, Sriram
    Saha, Sunanda
    Roy, Paromita
    Gupta, Sujoy
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2603 - S2604
  • [7] Low incidence of fatigue after hypofractionated stereotactic body radiation therapy for localized prostate cancer
    Dash, Chiranjeev
    Demas, Kristina
    Uhm, Sunghae
    Hanscom, Heather N.
    Kim, Joy S.
    Suy, Simeng
    Davis, Kimberly M.
    Sween, Jennifer
    Collins, Sean
    Adams-Campbell, Lucile L.
    FRONTIERS IN ONCOLOGY, 2012, 2
  • [8] A phase II trial of arc-based hypofractionated IMERT in localized prostate cancer.
    Best, L.
    Lock, M.
    Wong, E.
    Bauman, G.
    D'Souza, D.
    Venkatesan, V.
    Sexton, T.
    Ahmad, B.
    Rodrigues, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Phase I/II Study of Extreme Hypofractionated Stereotactic Body Radiation Therapy Boost to Prostate for Locally Advanced, Node-Positive and Oligometastatic Cancer
    Narang, Kushal
    Kadian, Mohit
    Venkatesan, K.
    Mishra, Saumyaranjan
    Bisht, Shyam
    Gupta, Deepak
    Banerjee, Susovan
    Kataria, Tejinder
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (11)
  • [10] A phase II study of hypofractionated proton therapy for prostate cancer
    Kim, Yeon-Joo
    Cho, Kwan Ho
    Pyo, Hong Ryull
    Lee, Kang Hyun
    Moon, Sung Ho
    Kim, Tae Hyun
    Shin, Kyung Hwan
    Kim, Joo-Young
    Le, Se Byeong
    Nam, Byong Ho
    ACTA ONCOLOGICA, 2013, 52 (03) : 477 - 485
12345